48.72USD+3.97%Mkt Cap: 3.85B USDP/E: 44.65Last update: 2026-06-01
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for …
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap3.85B USD
Enterprise Value3.30B USD
Revenue (TTM)541.74M USD
Gross Profit362.53M USD
Net Income (TTM)66.35M USD
Revenue/Share6.861 USD
Last Price48.72 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees755
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS92337F1075
Valuation
P/E (Trailing)44.65
P/E (Forward)24.33
PEG—
EV/EBITDA31.65
EV/Revenue6.09
P/S6.83
P/B2.81
EPS (TTM)1.08
EPS (Forward)1.91
52W Range
22.6193% of range50.71
52W High50.71 USD
52W Low22.61 USD
Profitability
Gross Margin70.10%
Oper. Margin16.28%
EBITDA Margin19.24%
Profit Margin12.83%
ROE5.07%
ROA4.72%
Growth
Revenue Growth21.50%
Earnings Growth288.90%
Cash Flow & Leverage
Operating CF136.31M USD
CapEx (TTM)9.68M USD
FCF Margin19.29%
FCF Yield2.72%
Net Debt-399.73M USD
Net Debt/EBITDA-3.84
Balance Sheet
Debt/Equity0.03
Current Ratio9.30
Quick Ratio8.72
Book Value/Sh16.50 USD
Cash/Share5.503 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)47.40 USD
Target Range37.00 USD – 55.00 USD
# Analysts10
Ownership
Shares Out.79.79M
Float79.36M
Insiders0.51%
Institutions113.30%
Short Interest
Short Ratio8.9d
Short % Float12.74%
Short % Out.10.77%
Shares Short8.59M
Short (prev mo.)6.45M
Technical
SMA 5035.99 (+35.4%)
SMA 20037.09 (+31.4%)
Beta1.89
S&P 52W Chg27.70%
Avg Vol (30d)943.63K
Avg Vol (10d)1.13M
Technical Indicators
RSI (14)71.6
MACD3.1199
MACD Signal2.5791
MACD Hist.+0.5408
BB Upper49.75 USD
BB Middle40.97 USD
BB Lower32.18 USD
BB Width42.91%
ATR (14)2.082 USD
Vol Ratio (20d)0.44x